ATRENEW INC (RERE) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:RERE - US00138L1089 - ADR
4.1 USD
+0.03 (+0.74%)
4.09 USD
-0.01 (-0.24%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.869B 26.85% | 12.966B 31.37% | 16.328B 25.93% | 21.335B 30.67% | 26.695B 25.12% | 31.444B 17.79% | |
| EBITDA YoY % growth | -398.3M 23.61% | 161M 140.42% | 296M 83.85% | 571.2M 92.97% | N/A | N/A | |
| EBIT YoY % growth | -803.7M 10.21% | -173M 78.47% | 29M 116.76% | 531.11M 1,731.41% | 771.02M 45.17% | N/A | |
| Operating Margin | -8.14% | -1.33% | 0.18% | 2.49% | 2.89% | N/A | |
| EPS YoY % growth | N/A 65.85% | N/A 172.64% | N/A -76.62% | 0.23 27.78% | 0.38 60.87% | 3.53 835.35% |
All data in CNY
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | 0.83 37.29% |
| Revenue Q2Q % growth | 6.289B 29.70% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | 167.99M 216.96% |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.50 34.61% | 0.61 | -0.11 | -18.62% |
| Q2 2025 Q2Q % growth | 0.41 28.12% | 0.58 | -0.17 | -29.48% |
| Q1 2025 Q2Q % growth | 0.48 269.23% | 0.61 | -0.13 | -21.57% |
| Q3 2024 Q2Q % growth | 0.37 72.47% | 0.56 | -0.19 | -34.05% |
| Q2 2024 Q2Q % growth | 0.32 113.33% | 0.51 | -0.19 | -37.25% |
| Q1 2024 Q2Q % growth | 0.13 -56.67% | 0.53 | -0.40 | -75.49% |
| Q3 2023 Q2Q % growth | 0.21 -28.49% | 0.12 | 0.09 | 75.27% |
| Q2 2023 Q2Q % growth | 0.15 400.00% | 0.42 | -0.27 | -64.13% |
| Q1 2023 Q2Q % growth | 0.30 236.36% | 0.21 | 0.09 | 40.06% |
| Q3 2022 Q2Q % growth | 0.30 335.18% | -0.19 | 0.49 | 254.80% |
| Q2 2022 Q2Q % growth | -0.05 96.92% | -0.45 | 0.40 | 88.86% |
| Q1 2022 Q2Q % growth | -0.22 | -0.24 | 0.02 | 8.11% |
| Q4 2021 Q2Q % growth | -0.19 | -0.20 | 0.01 | 3.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 5.146B 27.03% | 5.207B | -60.793M | -1.17% |
| Q2 2025 Q2Q % growth | 4.991B 32.16% | 4.891B | 100.465M | 2.05% |
| Q1 2025 Q2Q % growth | 4.653B 27.45% | 4.709B | -55.555M | -1.18% |
| Q4 2024 Q2Q % growth | 4.849B 25.18% | 4.898B | -49M | -1.00% |
| Q3 2024 Q2Q % growth | 4.051B 26.91% | 4.098B | -46.762M | -1.14% |
| Q2 2024 Q2Q % growth | 3.777B 43.24% | 3.793B | -16.297M | -0.43% |
| Q1 2024 Q2Q % growth | 3.651B 27.14% | 3.633B | 18.136M | 0.50% |
| Q4 2023 Q2Q % growth | 3.874B 29.93% | % | ||
| Q3 2023 Q2Q % growth | 3.192B 25.87% | 3.494B | -301.847M | -8.64% |
| Q2 2023 Q2Q % growth | 2.637B 22.88% | 2.918B | -281.324M | -9.64% |
| Q1 2023 Q2Q % growth | 2.872B 30.15% | 2.897B | -25.206M | -0.87% |
| Q4 2022 Q2Q % growth | 2.981B 22.39% | % | ||
| Q3 2022 Q2Q % growth | 2.536B 29.24% | 2.631B | -95M | -3.61% |
| Q2 2022 Q2Q % growth | 2.146B 14.88% | 2.416B | -270.3M | -11.19% |
| Q1 2022 Q2Q % growth | 2.207B 45.70% | 2.181B | 25.5M | 1.17% |
| Q4 2021 Q2Q % growth | 2.436B | 2.381B | 54.8M | 2.30% |
| Q1 2021 Q2Q % growth | 1.514B 118.78% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4.76% | 0% | 4.55% |
| Revenue | 0% | -2.34% | 0% | 2.59% |